2018: A banner year for hematology drug approvalsDecember 5, 2018Business of MedicineCLLAggressive LymphomasMixed Topics
Large cohort study IDs prognostic factors in thromboangiitis obliteransDecember 5, 2018Mixed TopicsThrombosis
NIH director expresses concern over CRISPR-cas9 baby claimNovember 28, 2018Mixed TopicsTranslational Research
ASH 2018 coming attractions look at the big pictureNovember 21, 2018Aggressive LymphomasMultiple MyelomaCLLAnemiaMixed TopicsB Cell Lymphoma
Study identifies potential biomarkers for an increased risk of SCARs-related mortalityNovember 21, 2018Patient & Survivor CareMixed Topics